We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
Consensus vs. actual, and revenue trend
Consensus PT $2.99 · 5 analysts
Stored first · Google News · Yahoo Finance (English)
Cathie Wood Just Bet Big on This Biotech Stock - The Motley Fool
Cathie Wood Just Bet Big on This Biotech Stock The Motley Fool
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy? - The Motley Fool
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy? The Motley Fool
Florida Biotech Firm Takes FDA to Court Over Biden Era Export Delays - Floridian Press
Florida Biotech Firm Takes FDA to Court Over Biden Era Export Delays Floridian Press
Nobel Laureate Jennifer Doudna enters AI protein design arena - Fierce Biotech
Nobel Laureate Jennifer Doudna enters AI protein design arena Fierce Biotech
Harnessing Biotechnology to Accelerate Advanced Biofuels Production - Department of Energy (.gov)
Harnessing Biotechnology to Accelerate Advanced Biofuels Production Department of Energy (.gov)
Kalshi launches biotech prediction markets pilot program - Kalshi News
Kalshi launches biotech prediction markets pilot program Kalshi News
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | After market close (AMC) | $0.08 | — | — | $46.15M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.37 | — | — | $48.99M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.02 | — | — | $147.36M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.33 | — | — | $95.97M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 16. | Truist Securities | — | Maintain | Buy → Buy | — | Truist Securities: Buy |
| 2026. 03. 13. | B. Riley Securities | — | Maintain | Neutral → Neutral | — | B. Riley Securities: Neutral |
| 2026. 03. 13. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2025. 08. 08. | B. Riley Securities | — | Downgrade | Buy → Neutral | — | B. Riley Securities: Buy → Neutral |
| 2025. 03. 13. | Craig-Hallum | — | Maintain | Buy → Buy | — | Craig-Hallum: Buy |
| 2024. 12. 16. | Craig-Hallum | — | Initiate coverage | — → Buy | — | Craig-Hallum: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.